Marvin L. White - Mar 4, 2022 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
President and CEO, Director
Signature
/s/ SoYoung Kwon, attorney-in-fact
Stock symbol
APVO
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
4
Date filed
3/4/2022, 05:13 PM
Previous filing
Feb 1, 2022
Next filing
May 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Stock Option (right to buy) Award $0 +28.8K $0.00 28.8K Mar 4, 2022 Common Stock 28.8K $5.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three approximately equal annual installments beginning on March 3, 2023.